Literature DB >> 13374364

Treatment of chronic renal oedema.

J B RENNIE.   

Abstract

Entities:  

Keywords:  EDEMA/therapy; KIDNEY DISEASES

Mesh:

Year:  1956        PMID: 13374364      PMCID: PMC2036039          DOI: 10.1136/bmj.2.5008.1506

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Treatment of the nephrotic syndrome with corticotropin (ACTH) and cortisone; a four-and-one-half-year survey of results with short-term courses.

Authors:  W HEYMANN; S SPECTOR; L W MATTHEWS; D J SHAPIRO
Journal:  AMA Am J Dis Child       Date:  1955-07

2.  Treatment of nephrosis with prednisolone.

Authors:  G C ARNEIL
Journal:  Lancet       Date:  1956-04-14       Impact factor: 79.321

3.  Therapy of the nephrotic syndrome: sodium restriction, dextran, and corticotropin (ACTH) alone or combined with nitrogen mustard.

Authors:  L GREENMAN; F A WEIGAND; T S DANOWSKI
Journal:  AMA Am J Dis Child       Date:  1955-02

4.  Treatment of renal oedema with dextran.

Authors:  A W MOLLISON; J B RENNIE
Journal:  Br Med J       Date:  1954-04-17

5.  Advances in management of the nephrotic state.

Authors:  J A LUETSCHER; Q B DEMING; B B JOHNSON; C F PIEL
Journal:  J Am Med Assoc       Date:  1953-12-05

6.  Effect of nitrogen mustard on clinical course of glomerulonephritis.

Authors:  D S BALDWIN; P G McLEAN; H CHASIS; W GOLDRING
Journal:  AMA Arch Intern Med       Date:  1953-08

7.  Cation exchange resin in treatment of the nephrotic syndrome.

Authors:  R W LIPPMAN
Journal:  AMA Arch Intern Med       Date:  1951-07
  7 in total
  2 in total

1.  [Renal effects of acetazolamide, chlorothiazide and chlormerodrin in experimental renal insufficiency. Part IV. Comparison of the influences of various kidney function disorders].

Authors:  H BRUNNER
Journal:  Klin Wochenschr       Date:  1959-11-01

2.  Salt-poor human albumin in management of nephrotic syndrome.

Authors:  A M Davison; A T Lambie; A H Verth; J D Cash
Journal:  Br Med J       Date:  1974-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.